Skip to main content
. 2017 Oct 15;26(20):1460–1467. doi: 10.1089/scd.2016.0310

FIG. 2.

FIG. 2.

Comparing the expression rates of CLL-1 in different stage cells of AML (A) and control group (B). The expression rate of CLL-1 was 62.6% (77/123) in de novo AML leukemia cells and 86.5% (20/23) in the control group, with the de novo AML group being significantly lower than the control group (P < 0.05), whereas the difference between the myeloid cells from the two groups was not significant (P = 0.22). *P < 0.05